Holen Sie sich die Stockscreener-App
3.34
13.22%
0.39
Schlusskurs vom Vortag:
$2.95
Offen:
$6.76
24-Stunden-Volumen:
39.23M
Relative Volume:
3.96
Marktkapitalisierung:
$19.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.32M
KGV:
-0.2628
EPS:
-12.7107
Netto-Cashflow:
$-7.30M
1W Leistung:
+8.09%
1M Leistung:
+14.78%
6M Leistung:
+118.29%
1J Leistung:
+24.16%
1-Tages-Spanne:
$3.154
$6.89
1-Wochen-Bereich:
$2.85
$6.89
52-Wochen-Spanne:
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Firmenname
Tharimmune Inc
Sektor
Branche
Telefon
302-743-2995
Adresse
1200 ROUTE 22 EAST, BRIDGEWATER
Vergleichen Sie THAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
3.3686 | 22.45M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.12 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tharimmune Inc Aktie (THAR) Neueste Nachrichten
Tharimmune Amends Warrants Agreement to Boost Liquidity - MSN
What insider trading reveals about Tharimmune Inc. stockWeekly Market Outlook & Daily Price Action Insights - newser.com
Will Tharimmune Inc. stock sustain high P E ratios2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Does Tharimmune Inc. fit your quant trading model2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
What the charts say about Tharimmune Inc. todayTrade Entry Report & Consistent Profit Alerts - newser.com
Using data models to predict Tharimmune Inc. stock movementMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Will earnings trigger a reversal in Tharimmune Inc.Quarterly Investment Review & Safe Entry Trade Reports - newser.com
Will Tharimmune Inc. continue its uptrendWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Why analysts upgrade Tharimmune Inc. stock2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com
Is Tharimmune Inc. stock attractive for retirement portfoliosPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Is Tharimmune Inc. still worth holding after the dipOil Prices & Low Drawdown Investment Strategies - newser.com
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments - Pueblo Chieftain
What analysts say about Tharimmune Inc stockSector-Based Investing & Maximize Returns With Insights - earlytimes.in
How resilient is Tharimmune Inc. stock in market downturns2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
Can Tharimmune Inc. stock continue upward trendQuarterly Growth Report & Reliable Breakout Forecasts - fcp.pa.gov.br
Tharimmune’s New Study on TH104: A Potential Game-Changer for PBC Treatment - TipRanks
Tharimmune, Inc.Common Stock (NQ: THAR - FinancialContent
Finanzdaten der Tharimmune Inc-Aktie (THAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):